Noteworthy News Articles on Mental Health Topics, October 26-31, 2005
Associated Press, 10/27/2005 BURLINGTON, Vt. --Vermont is offering smokers online help to quit. The Vermont Department of Health will cover the $100 fee for smokers to use QuitNet, an Internet site that offers suggestions for how to quit and a chat room where participants can provide support to one another. Health Department officials think the Web site will lure young, computer-experienced smokers who want to give up the habit. "We have had a quit line for a while that offers counseling by telephone," said Sheri Lynn, head of smoking cessation for the health department. Hospitals also offer quit programs, she said. "Now we have the Internet. It is more self-directed. You can set your own pace," she said. The state has allocated about $40,000 to pay for Vermonters to use QuitNet. Lynn said the expenditure will both improve Vermonters' health and help decrease medical costs. About 20 percent of Vermont adults smoke, officials estimate. The Department of Health hopes to reduce smoking rates among adults to 10 percent in five years. The number of young smokers has dropped from 31 percent of eighth to 12th grade students who smoked six years ago to 16 percent now. Information from: The Burlington Free Press, http://www.burlingtonfreepress.com Ex-Religious Brother Charged with Rape Maria Cramer, Boston Globe- 10/28/2005 The frail-looking former religious brother faced charges of raping two boys yesterday as one of his accusers looked on and sobbed. Edward Anthony Holmes, 64, softly pleaded not guilty in Suffolk Superior Court to six counts of rape of a child, five counts of indecent assault and battery on a child under 14, five counts of indecent assault and battery on a child over 14, and one count of photographing a nude child. Holmes is accused of raping the children during the 1970s and early 1980s while he was a resident counselor at the now-defunct Nazareth Child Care Center in Jamaica Plain, said Audrey Mark, an assistant district attorney. Holmes was ordered to post $15,000 cash bail and stay away from children under age 16. One of his two accusers, now a 39-year-old carpenter, sat on the wooden bench in the courtroom, clutching it with his hands and crying loudly. Holmes never looked at him. ''You don't know how hard this is," the man said moments before he entered the courtroom. ''The last time I saw him I was 4 feet, 65 pounds." Asked what was done to him, he responded: ''The unthinkable." Holmes was living in Washington near his family for more than a decade, supporting himself as a secretary for a monastery, said his lawyer, Jeanne Carol. ''He maintains his innocence," she said. Around 1964, Holmes joined the Congregation of the Sacred Hearts of Jesus and Mary, said the Rev. David P. Reid in a telephone interview yesterday. The Roman Catholic community, based in Fairhaven, is under the auspices of the Diocese of Fall River. Holmes left the community in 2002, Reid, the congregation's provincial, said. He declined to give the reason but said it was not related to the allegations. ''We knew nothing about the allegations until after he had left," Reid said. He said he has known Holmes since the 1960s and described him as a ''kind, caring, gentle soul." ''All these alleged actions, they are a shock to us," Reid said. Prosecutors from Suffolk District Attorney Daniel F. Conley's office began investigating the allegations after the two accusers came forward in 2003. They decided to pursue criminal charges, according to the alleged victim who was present yesterday, after Holmes was named in the $85 million global settlement between the Archdiocese of Boston and sex abuse victims in the summer of 2003. A grand jury convened in August and voted to indict Holmes last month, said David Procopio, Conley's spokesman. Washington police arrested him last Friday. Holmes worked at the Nazareth Child Care Center from 1971 to 1985, Mark said. The center, run by the Daughters of Charity, for 121 years served as a residential program for children who needed a place to stay before being placed in foster care. The children were housed in the 10 cottages on the 35-acre property in Jamaica Plain. The center closed in 1985, partly because of financial difficulties, according to an August 1985 Globe article. During his tenure at the center, Holmes was also a supervisor at one of the cottages, Mark said, adding that he used his position to convince the children that only he had the authority to let them leave, she said. ''He would ensure in that process that the children complied with his sexual demands," she said during the arraignment. Holmes allegedly began abusing the first accuser, a 10-year-old, in 1976. The abuse continued until 1980, when the child turned 14. He began abusing the second boy, a 9-year-old, in 1977 and stopped in 1983, when the child turned 15, Mark said. He allegedly photographed the second accuser during the assaults, she said. In 1989, while he was living in Milton, his housemate found numerous photographs of Holmes and a young boy engaged in sexual activity, Mark said. Alex Raksin, Los Angeles Times- 10/29/2005 Researchers have identified a single gene alteration that may be a significant cause of dyslexia, a disorder that impairs the ability to comprehend written words. Dr. Jeffrey R. Gruen, an associate professor of pediatrics at the Yale University School of Medicine, said an analysis of DNA from 153 families showed that a gene known as DCDC2 may be responsible for as much as 20% of dyslexia cases. Researchers have associated DCDC2 with dyslexia since 1994, but Gruen said his research was the first to assign it such a key role. Using neural imaging, Gruen's team found that a mutated version of the gene — with a large deleted sequence — disrupted the way the dyslexics' brains sent and received impulses from the retina to the visual cortex. Speaking Friday at a meeting of the American Society of Human Genetics in Salt Lake City, Gruen said he altered the corresponding gene in rats and was able to disrupt the formation of the same brain circuits that impaired reading ability in humans. Some dyslexia researchers questioned Gruen's conclusion that a single gene could play such a prominent role in a condition as complex as dyslexia, which afflicts as many as 10% of U.S. children. Gruen acknowledged that many other genes were involved in dyslexia, but his statistical analysis showed strong evidence of DCDC2's central role. Gruen said the finding could lead to genetic testing that would allow earlier diagnoses of dyslexia, which can be ameliorated through phonics training.
Jeanne Safer, New York Times Book Review- 10/30/2005 In May 2004, "Father Joe: The Man Who Saved My Soul," by Tony Hendra, the satirist and former National Lampoon editor, was published to ecstatic acclaim. An account of Hendra's 40-year relationship with a charismatic Benedictine monk, the Rev. Joseph Warrilow, the book received a cover review in these pages from Andrew Sullivan, who said it belonged "in the first tier of spiritual memoirs" and noted that it "spares us no detail of his own iniquities as a parent." Frank McCourt likened "Father Joe" to the writings of St. Augustine, and Don Imus promoted it as a Father's Day gift for six weeks. Very soon, however, there was trouble in paradise. A letter to the editor appeared in The New York Times Book Review claiming that Hendra had overstated his role in creating the movie "This Is Spinal Tap"; "I think Tony Hendra is at least one confession away from salvation," its author, one of the writers of the film, observed. That might be two confessions away. An investigative report by N. R. Kleinfield headlined "Daughter Says Father's Confessional Book Didn't Confess His Molestation of Her," also in The Times, followed within weeks. Jessica Hendra, 39, had contacted the newspaper after reading "Father Joe" and accused her father of having omitted three episodes of sexual abuse from his redemption narrative. Kleinfield spoke with two therapists who had treated her and three of her friends, one of whom she had told of the abuse at the age of 12. Her mother, who initially pleaded ignorance to Kleinfield, later called him back to say that her former husband had actually confessed the last episode to her. (Tony Hendra has called the allegations "outrageous.") Jessica Hendra's memoir, "How to Cook Your Daughter," written with Blake Morrison, a journalist, provides details of her father's behavior and character that she asserts he omitted from "Father Joe." But rather than being a systematic refutation of his confessional, it is an exorcism from which the reader emerges shaken and aghast. The books of the two Hendras could not be more different, although the man who wrote the first is clearly identifiable, if far darker, in the second. His prose in "Father Joe" is agile and ironic; hers rarely rises above pedestrian reportage. The reader comes away convinced that Tony Hendra glosses over far too much in his story, but also that Jessica Hendra provides more specifics about the mechanics of bulimic vomiting than is absolutely necessary. Hendra père accuses himself of largely ignoring his first family (he has two children from a previous marriage, which ended in divorce, and three children from his current marriage), while his daughter's book portrays him as far too ominously present, even when he disappears for days at a time. The Hendra family values depicted in "How to Cook Your Daughter" include mental cruelty, explosive rages and exposure to danger (speeding drunk through the Holland Tunnel, leaving cocaine in the refrigerator), as well as orgiastic drug binges and full frontal nudity with his Lampoon cronies. Jessica Hendra's mother seems to have protected her from none of it. There were also violent or perverse photo shoots featured in National Lampoon - one of Jessica, her sister and other children dressed as child pimps and prostitutes is on the book's cover - and enough instances of physical neglect that, if true, make one wonder how the girls avoided being removed by child welfare authorities. There were also, tragically, tender moments between Jessica and the gifted, magnetic father she adored and with whom she identified so closely that she got thrown out of a Brownie troop for cursing like him. In two episodes -- one sickening, the other exhilarating -- this memoir rises above simply rebutting her father's view of the truth and becomes literature of moral power. The scene as recounted in the book in which she tells her therapist that her father forced her to perform oral sex on him when she was 6, that he threatened to leave home if she did not comply and tucked her in afterward, is intercut with excerpts from the Lampoon piece the book is named for, written just months before the night she describes. Its details eerily symbolize and presage the abuse ("People so often ask, 'How do I tell when my daughter is ready for the table?' Well, there's always some little variation, but generally the exact age falls somewhere between the fifth and sixth birthdays"). The other is an inner dialogue in which Jessica Hendra decides to go public with her accusations and take the consequences. And what of the spiritual issues raised in "Father Joe"? In researching a book I wrote about forgiveness a few years ago, I asked religious leaders whether an unrepentant abusive parent would merit absolution. A rabbi stated that there should be no forgiveness without contrition. Jessica Hendra agrees: "I believe in what Father Warrilow preached: that everything can be forgiven. But first, there has to be acknowledgment, real acknowledgment, of the transgression." From what is presented here, a reader has to conclude that Tony Hendra does not yet qualify. Father Joe may not have saved him, but in writing her book, his daughter may have saved herself.
Daniel Costello, Los Angeles Times- 10/31/2005 SAN FRANCISCO — Denise Williams, a frail and homeless heroin addict, fills her sandwich bag with a dozen clean needles and wanders to the back of the crowded Tenderloin health clinic for a five-minute lesson. It's a crash course on how to save a life. Leaning over a dummy on the floor, Williams, 50, practices breathing into the mouth of someone out cold. She then collects two free needles preloaded with naloxone, a medication that can revive an overdosing opiate addict within minutes, and is on her way. "I'm glad they're showing us this stuff," said Williams, who was revived with a dose of naloxone herself last summer. "I don't want to just sit there if someone ends up in a bad situation." Mostly because of drug abuse among baby boomers, Californians are dying of overdoses in such large numbers that they may soon surpass auto accidents as the state's leading cause of accidental death. But here in San Francisco, the death rate from overdose is at its lowest level in nearly a decade. In 2003, the latest year for which the state has figures, a record 3,691 drug users died, up 42% since 1998 and up nearly 75% since 1990. The total surpasses deaths from firearms, homicides and AIDS. Meanwhile, overdose deaths in San Francisco, which has one of the highest rates of drug use in the state, have fallen from 178 in 1998 to 144 two years ago. Since then, officials believe, the number may have dropped to fewer than 100 deaths. The training of addicts to save their brethren is one reason, public health officials say. Officials here have embraced a number of "harm reduction" practices in recent years. And the city has focused primarily on middle-aged users, whose rate of overdose statewide has doubled in the last dozen years. The approach is controversial because it bypasses the "Say No" and "Get Treatment Now" messages. It assumes overdoses will occur and strives mostly to keep addicts from dying. Critics, including some physicians, worry that public funding of such a program endorses addiction. "Addiction is a disease, and overdoses are simply a symptom of the disease," said Dr. David Smith, medical director of the Haight Ashbury Free Clinics, one of San Francisco's largest drug treatment providers, which does not distribute naloxone. "We believe we should be focusing more on getting people into treatment." Naloxone works by blocking opiates from attaching to the brain's pleasure-seeking receptors. It sends users into immediate — and often agonizing — withdrawal. Still, many doctors say the medication does not have proven long-term harmful effects. In 2003, San Francisco became the first city in the state to publicly fund naloxone distribution, which now costs about $50,000 a year. Since then, officials say, addicts have reported saving 116 people with the medication, although this could not be independently verified. Naloxone distribution is part of a larger campaign aimed at keeping addicts from getting high by themselves. Four years ago, the public health department began posting "Fix It With a Friend" billboards around the city, highlighting the risks of solo use. Two of San Francisco's biggest overdose targets are single-room occupancy hotels and the Tenderloin district, because they typically attract older addicts. Older addicts often use drugs alone, while younger people, research shows, tend to use them in groups. One of the major risk factors for a fatal overdose is not having anyone to call paramedics when the first signs of an overdose appear. The city also has joined forces with a nonprofit group that sends volunteers to local jails and treatment centers to warn about the risks of starting up drug use again even after a short hiatus. They often pass out "Got Naloxone?" stickers, reminiscent of milk commercials. Experts estimate that a quarter of overdoses occur soon after addicts leave treatment or jail. Peter Morse, a pierced and tattooed overdose prevention counselor with the city-supported D.O.P.E. Project (Drug Overdose Prevention and Education), said one of the hardest tasks is convincing people that it's worthwhile to save addicts who are essentially killing themselves. "This makes their situation not so hopeless," Morse said as he walked down a trash-strewn block in the Tenderloin, which he called one of the city's drug-abuse epicenters. "This doesn't have to be a death sentence for them." Williams, who has been using heroin since she was 21, said a friend administered naloxone to her early this summer. Minutes later, she woke up on the street as the ambulance was arriving, in pain and nauseated. "It made me feel cold, and it left a real bad taste in my mouth," she said. "I'm glad they did it, but I didn't like the feeling." Among junkies, word is spreading about naloxone. Jack Rocchetti, 40, recently came to a needle exchange seeking naloxone training. He learned about the medication a week before, when one friend used it on another. Rocchetti, a beefy former fork lift operator with a rosary around his neck, has been using heroin on and off for 18 years. He stopped for almost a year until last April, he said, when he started using again because of a depression over a midlife crisis. "I'm 40 years old, and I don't have much to show for it," he said. "I'm starting to get too old for this." The city's overdose prevention campaign has been driven in part by research. A UC San Francisco study examining overdose deaths in San Francisco in the late 1990s, one of the few such analyses on the topic, showed that close to half the city's overdoses were among older users who lived in single-room occupancy hotels. And more than a third of the deaths were within 500 meters of one intersection — Turk and Jones streets — in the Tenderloin. "One of the things people will tell you is that we should focus on trying to get addicts in treatment," said Dr. Josh Bamberger, medical director of the San Francisco Department of Health's division of Housing and Urban Health. "You can't get a dead addict into treatment." In interviews, state and local health officials in Los Angeles acknowledge that, other than in San Francisco, there is virtually no strategy to address the statewide rise in drug deaths. "We have been focused on expanding our needle exchanges and have a limited amount of money to use," said Dr. Jonathan Fielding, Los Angeles County's health officer. He said he had not been aware of San Francisco's success in reducing overdose deaths in recent years and may recommend that Los Angeles begin a naloxone distribution program. Around the nation, a handful of cities and states, including Baltimore, Chicago and Santa Fe, N.M., have instituted overdose prevention plans and have begun distribution of naloxone. Their overdose deaths are down as much as 30% since their naloxone programs began. More recently, health officials in California's Humboldt County began distributing a small number of naloxone needles last year, and New York state legalized distribution this summer. Dan Bigg, director of the Chicago Recovery Alliance, a nonprofit harm reduction coalition, said he had no doubt naloxone and harm reduction were effective. "What we have here is an antidote to the problem," he said. "Now we just have to convince people it's worth it."
Shari Roan, Los Angeles Times-10/31/2005 Copy machines that talk. Co-workers conspiring to kill. These are the kinds of bizarre hallucinations and delusions that have driven people with schizophrenia from schools and workplaces and deposited them on the lonely margins of society. Now, however, doctors are discovering that other well-known, but much less flamboyant, symptoms of the brain disorder may be just as significant in preventing schizophrenics from engaging in the real world. Mental confusion, apathy and the inability to experience pleasure are now thought to be major barriers to a return to mainstream life. Such symptoms are hard to treat. Though a number of antipsychotic medications can help blot out the so-called "positive" symptoms of schizophrenia — the disorienting and disturbing hallucinations and delusions — there are no medications to treat the cognitive impairment and emotional symptoms. In recent years, researchers have started seeking therapies for these so-called "negative" symptoms of schizophrenia, says Dr. Stephen Marder, a professor of psychiatry at the Semel Institute for Neuroscience and Human Behavior at UCLA and director of the mental health research, education and clinical center for the VA Greater Los Angeles Health Care System. The impetus has been the recovery movement, an effort by patients, their families and other mental health advocates that aims not to "cure" the disease but to restore schizophrenics as functioning members of society. "The recovery movement is saying, 'You can go just so far in improving positive symptoms, but we also want to be able to socialize, to work and make progress in our lives,' " says Marder, who has helped spearhead a national research effort addressing the problem. "If that is going to happen, it's likely we're going to have to develop drugs that address those areas." The cognitive and emotional problems can be deeply crippling. People with schizophrenia "seem like they have a lack of ability to express themselves," Marder says. "They are also oftentimes apathetic. Some will say, 'I would really like to do things, but I can't get myself interested in doing it.' " College students experiencing their first psychotic episode often find they can no longer continue school even if promptly treated with antipsychotics and the hallucinations are resolved, he says. "They'll find their grades deteriorate. Reading and studying and focusing their attention becomes so difficult." Improving quality of life The search for treatments for these problems represents a dramatic shift in drug development goals for schizophrenia. As recently as a decade ago, doctors and patients rejoiced in a new family of antipsychotic medications aimed at reducing hallucinations and delusions without many of the severe side effects linked to the older antipsychotic drugs. Older drugs, such as Haldol, typically cause tremors and muscle rigidity. But the new so-called atypical antipsychotics, though helpful to many, haven't led to sweeping improvements in quality of life, experts acknowledge. In an 18-month study released last month, researchers found that three-quarters of the patients stopped taking their assigned drugs before the trial's conclusion because the medications didn't improve their condition enough or because of side effects such as tremors or significant weight gain. Even with treatment, about 85% of schizophrenics are unemployed, according to the National Institute of Mental Health. "Ten years ago, there was a hope that the newer medications would give us a greater chance at recovery, the vanishing of the disorder," says Dr. Thomas R. Insel, director of NIMH. "I think [the study] makes clear that the medications we currently have are necessary but not sufficient." Several drug companies are continuing to seek better antipsychotic drugs. But the main focus of research within the government and academia is on better understanding the negative symptoms of the disease. For decades, scientists have blamed schizophrenic symptoms on abnormalities in the brain chemical dopamine — and these are, indeed, linked to the delusions and hallucinations. But new research suggests other brain chemicals are involved in the disorder, contributing to such symptoms as confusion and emotional unresponsiveness. NIMH is collaborating with universities and industry to identify possible new medications for cognitive deficits and develop better instruments for assessing improvements. Ideally, these new medications would give people with schizophrenia the ability to concentrate, carry out tasks and interact socially. Avenues of study One promising substance is a drug, D-cycloserine, that is used to control tuberculosis. D-cycloserine works on a structure in the brain known in shorthand as the NMDA receptor, which plays a key role in learning and memory. It's believed that some of the symptoms of schizophrenia are caused by a blockage or abnormality of this receptor; D-cycloserine appears to unblock it. Studies on D-cycloserine drugs for schizophrenia are still in early stages. But one study, reported in March in the journal Biological Psychiatry, showed that 39 people with schizophrenia taking D-cycloserine in addition to a traditional antipsychotic experienced improvements in a range of symptoms, including hallucinations, delusions, apathy, withdrawal and cognitive deficits. Another avenue of study involves targeting a serotonin receptor that is critical to cognitive function. Saegis Pharmaceuticals, a company in Half Moon Bay, Calif., is partnering with Eli Lilly & Co. in phase 2 testing of a drug, SGS518, which blocks this receptor, with the hope of improving cognitive functioning. Meanwhile, San Diego's Acadia Pharmaceuticals is studying a chemical that may help subdue psychotic symptoms as well as improve cognition. The company is on track to present results from phase 2 studies within a year, said chief executive officer Uli Hacksell. "There is a lot of excitement about the ability to improve the negative symptoms in schizophrenia," Hacksell says. "It's time to do something about this part of the symptomology of the disease that hasn't been dealt with so far." Drugs, however, will take recovery only so far. Non-drug treatments are also important. For example, Insel says, a program called supportive employment — in which employees receive job coaching, support, even transportation — can boost employment rates from 10% to 50%. Educating family members, and engaging them as part of the treatment team, can also sharply reduce the relapse rate. "This whole push for recovery is very important, but I don't think medications are going to be the largest part of that story," Insel says. "I think we have some very good [nonmedical] treatments that are not used nearly enough. We need multiple forms of care, not just medication." |